United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-006_4eb20508-df76-1a2a-e063-6394a90a5f40
- Product NDC
- 85766-006
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070731
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (85766-006-00) · 85766-006-00
- 3 TABLET, FILM COATED in 1 BOTTLE (85766-006-03) · 85766-006-03
- 500 TABLET, FILM COATED in 1 BOTTLE (85766-006-05) · 85766-006-05
- 6 TABLET, FILM COATED in 1 BOTTLE (85766-006-06) · 85766-006-06
- 8 TABLET, FILM COATED in 1 BOTTLE (85766-006-08) · 85766-006-08
- 10 TABLET, FILM COATED in 1 BOTTLE (85766-006-10) · 85766-006-10
- 24 TABLET, FILM COATED in 1 BOTTLE (85766-006-24) · 85766-006-24
- 30 TABLET, FILM COATED in 1 BOTTLE (85766-006-30) · 85766-006-30
- 60 TABLET, FILM COATED in 1 BOTTLE (85766-006-60) · 85766-006-60
- 90 TABLET, FILM COATED in 1 BOTTLE (85766-006-90) · 85766-006-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →